Tech Company Financing Transactions
BiPar Sciences Funding Round
Lighthouse Capital Partners joined a $5 million venture round for BiPar Sciences. The funding round was announced on 6/14/2006.
Transaction Overview
Company Name
Announced On
6/14/2006
Transaction Type
Debt
Amount
$5,000,000
Round
Undisclosed
Investors
Proceeds Purpose
The company plans to use the funding to accelerate and expand the clinical program for its lead compound, BSI-201, and move two additional compounds toward clinical development.
Company Information
Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
1000 Marina Blvd. 550
Brisbane, CA 94005
USA
Brisbane, CA 94005
USA
Phone
Website
Email Address
Overview
BiPar Sciences Inc. is a clinical-stage biopharmaceutical company developing and commercializing a novel class of tumor-selective drugs designed to meet the significant unmet needs of cancer patients.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Hoyoung Huh
Chief Financial Officer
John Schembri
Vice President
Barry Sherman
Vice President
Charles Bradley
VP - Marketing
Sunil Patel
VP - Regulatory Affairs
Deborah Thomas
Browse more venture capital transactions:
Prev: 6/14/2006: Novelion Therapeutics venture capital transaction
Next: 6/14/2006: Aveksa venture capital transaction
Share this article
News on VC Transactions
We do our best to report on every notable VC transaction. VC investment data records reported here are derived from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs